Medtronic announced the start of the SPYRAL AFFIRM study, which is evaluating the long-term safety, efficacy, and durability of renal denervation with Medtronic’s Symplicity system in “real-world” patients with uncontrolled hypertension.
The study was granted an investigational device exemption in June and began in early November with the enrollment of the...